# Senate Bill to Repeal 24% Wholesale Marijuana Tax in Michigan > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/michigan-marijuana-wholesale-tax-repeal-bill/ > **Published:** 2026-04-24T16:49:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:11:22-04:00 > **Clinical Summary:** Explore the Michigan marijuana wholesale tax repeal bill and its impact on cannabis pricing, patient access, and the legal market. --- ✦ New CED Clinical Relevance #38 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyIndustryTHC Clinical Summary A proposed Senate bill aims to eliminate the 24 percent wholesale tax currently applied to marijuana products, which proponents argue has inflated retail prices and driven consumers toward illicit markets. The tax burden is passed downstream to patients and consumers, potentially pricing out individuals who might benefit from cannabis therapeutically, particularly those without insurance coverage or substantial disposable income. Repealing this wholesale tax could lower retail prices, improve access to regulated products with known potency and purity, and reduce the price differential between legal and illegal markets. For clinicians, lower prices may increase patient adherence to cannabis-based treatment regimens and reduce barriers to accessing standardized, tested products rather than unregulated alternatives. Policymakers argue that increased affordability could also expand the legal market and generate tax revenue through increased sales volume, benefiting [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) oversight. Clinicians should monitor these policy developments, as changes to cannabis pricing and availability directly influence patient access to therapeutic options and the overall viability of cannabis medicine in clinical practice. Dr. Caplan’s Take “I’ve watched the tax burden on legal cannabis create a two-tiered system where my patients with means access tested, quality-controlled products while others default to illicit markets with no quality assurance, and repealing this tax could meaningfully improve [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) by bringing more patients into the regulated supply chain. The wholesale tax isn’t just economics; it’s a public health policy that directly affects which patients can afford consistent, safe dosing.” Clinical Perspective While proposed tax reductions on cannabis may improve affordability and market accessibility, clinicians should recognize that lower prices could potentially increase consumption frequency and normalize use among patients already managing substance use disorders or psychiatric conditions. The relationship between cannabis taxation and actual consumption patterns remains incompletely understood, with competing evidence about whether price elasticity significantly influences use in medical versus recreational populations. Healthcare providers encountering patients in states considering such policy changes should remain alert to shifting use patterns and potential escalation of cannabis-related problems, particularly among vulnerable groups such as adolescents, pregnant individuals, and those with psychotic or addictive disorders. Tax policy debates often occur outside clinical awareness, yet they can meaningfully alter the cost-benefit calculus patients use when deciding whether to initiate or increase cannabis use. Clinicians are encouraged to maintain open conversations about cannabis access, cost, and patterns of use as part of routine substance screening, while recognizing that legislative changes affecting pricing may reshape 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Senate+Bill+would+repeal+24%25+wholesale+tax+on+%3Cb%3Emarijuana%3C%2Fb%3E+-+WTVB+%40drcaplan&url=https%3A%2F%2Ftvbam.com%2F2026%2F02%2F27%2F903595)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Ftvbam.com%2F2026%2F02%2F27%2F903595)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Senate+Bill+would+repeal+24%25+wholesale+tax+on+%3Cb%3Emarijuana%3C%2Fb%3E+-+WTVB+--+via+%40drcaplan.bsky.social+https%3A%2F%2Ftvbam.com%2F2026%2F02%2F27%2F903595)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 239 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-digest-march-17-2026/) - [CED Digest: 230 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-research-digest-march-2026/) 📰 Source: [https://tvbam.com/2026/02/27/903595](https://tvbam.com/2026/02/27/903595) Further Reading CED Clinic Blog[What the DOJ Cannabis Order Means for Patients and Clinicians](https://cedclinic.com/medical-cannabis-schedule-iii-order/) Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items Evidence Watch[Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review.](https://cedclinic.com/mechanistic-pathways-insomnia-cbd-hemp-sesame-oil/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Illinois Updates Cannabis Regulations](https://cedclinic.com/illinois-updates-cannabis-regulations/) Learn about recent cannabis regulatory changes in Illinois and their effects on the medical and recreational markets. [Read Illinois Cannabis Updates](https://cedclinic.com/illinois-updates-cannabis-regulations/) [Law and Politics: Why Marijuana Rescheduling's One-Sided Hearing Matters](https://cedclinic.com/law-and-politics-why-marijuana-reschedulings-one-sided-hearing-matters/) Explore the political and legal nuances of marijuana rescheduling and its impact on research and policy. [Explore Marijuana Rescheduling](https://cedclinic.com/law-and-politics-why-marijuana-reschedulings-one-sided-hearing-matters/) [Virginia Lawmakers And Governor 'Have A Deal' On Bill To Legalize Marijuana Sales](https://cedclinic.com/virginia-lawmakers-and-governor-have-a-deal-on-bill-to-legalize-marijuana-sales-this-month/) Stay informed on Virginia's legislative progress toward legalizing marijuana sales and its implications for patients. [Follow Virginia Marijuana Bill](https://cedclinic.com/virginia-lawmakers-and-governor-have-a-deal-on-bill-to-legalize-marijuana-sales-this-month/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).